Literature DB >> 23934194

Epithelial ovarian cancer experimental models.

E Lengyel1, J E Burdette2, H A Kenny1, D Matei3, J Pilrose4, P Haluska5, K P Nephew4, D B Hales6, M S Stack7.   

Abstract

Epithelial ovarian cancer (OvCa) is associated with high mortality and, as the majority (>75%) of women with OvCa have metastatic disease at the time of diagnosis, rates of survival have not changed appreciably over 30 years. A mechanistic understanding of OvCa initiation and progression is hindered by the complexity of genetic and/or environmental initiating events and lack of clarity regarding the cell(s) or tissue(s) of origin. Metastasis of OvCa involves direct extension or exfoliation of cells and cellular aggregates into the peritoneal cavity, survival of matrix-detached cells in a complex ascites fluid phase and subsequent adhesion to the mesothelium lining covering abdominal organs to establish secondary lesions containing host stromal and inflammatory components. Development of experimental models to recapitulate this unique mechanism of metastasis presents a remarkable scientific challenge, and many approaches used to study other solid tumors (for example, lung, colon and breast) are not transferable to OvCa research given the distinct metastasis pattern and unique tumor microenvironment (TME). This review will discuss recent progress in the development and refinement of experimental models to study OvCa. Novel cellular, three-dimensional organotypic, and ex vivo models are considered and the current in vivo models summarized. The review critically evaluates currently available genetic mouse models of OvCa, the emergence of xenopatients and the utility of the hen model to study OvCa prevention, tumorigenesis, metastasis and chemoresistance. As these new approaches more accurately recapitulate the complex TME, it is predicted that new opportunities for enhanced understanding of disease progression, metastasis and therapeutic response will emerge.

Entities:  

Mesh:

Year:  2013        PMID: 23934194      PMCID: PMC3990646          DOI: 10.1038/onc.2013.321

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  156 in total

Review 1.  Ovarian surface epithelium: biology, endocrinology, and pathology.

Authors:  N Auersperg; A S Wong; K C Choi; S K Kang; P C Leung
Journal:  Endocr Rev       Date:  2001-04       Impact factor: 19.871

Review 2.  Recent advances in three-dimensional multicellular spheroid culture for biomedical research.

Authors:  Ruei-Zeng Lin; Ruei-Zhen Lin; Hwan-You Chang
Journal:  Biotechnol J       Date:  2008-10       Impact factor: 4.677

3.  An activating Pik3ca mutation coupled with Pten loss is sufficient to initiate ovarian tumorigenesis in mice.

Authors:  Kathryn M Kinross; Karen G Montgomery; Margarete Kleinschmidt; Paul Waring; Ivan Ivetac; Anjali Tikoo; Mirette Saad; Lauren Hare; Vincent Roh; Theo Mantamadiotis; Karen E Sheppard; Georgina L Ryland; Ian G Campbell; Kylie L Gorringe; James G Christensen; Carleen Cullinane; Rodney J Hicks; Richard B Pearson; Ricky W Johnstone; Grant A McArthur; Wayne A Phillips
Journal:  J Clin Invest       Date:  2012-01-03       Impact factor: 14.808

4.  Oral contraceptives decrease the prevalence of ovarian cancer in the hen.

Authors:  Lindsey S Treviño; Elizabeth L Buckles; Patricia A Johnson
Journal:  Cancer Prev Res (Phila)       Date:  2011-12-01

5.  Ovarian tumor expression of an oviductal protein in the hen: a model for human serous ovarian adenocarcinoma.

Authors:  James R Giles; H L Shivaprasad; Patricia A Johnson
Journal:  Gynecol Oncol       Date:  2004-12       Impact factor: 5.482

6.  Conditional inactivation of Brca1 in the mouse ovarian surface epithelium results in an increase in preneoplastic changes.

Authors:  Katherine V Clark-Knowles; Kenneth Garson; Jos Jonkers; Barbara C Vanderhyden
Journal:  Exp Cell Res       Date:  2006-10-03       Impact factor: 3.905

7.  Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/beta-catenin and PI3K/Pten signaling pathways.

Authors:  Rong Wu; Neali Hendrix-Lucas; Rork Kuick; Yali Zhai; Donald R Schwartz; Aytekin Akyol; Samir Hanash; David E Misek; Hidetaka Katabuchi; Bart O Williams; Eric R Fearon; Kathleen R Cho
Journal:  Cancer Cell       Date:  2007-04       Impact factor: 31.743

8.  Human ovarian carcinoma metastatic models constructed in nude mice by orthotopic transplantation of histologically-intact patient specimens.

Authors:  X Fu; R M Hoffman
Journal:  Anticancer Res       Date:  1993 Mar-Apr       Impact factor: 2.480

9.  Ovarian tumors of the hen.

Authors:  T N Fredrickson
Journal:  Environ Health Perspect       Date:  1987-08       Impact factor: 9.031

10.  Human tumour xenografts established and serially transplanted in mice immunologically deprived by thymectomy, cytosine arabinoside and whole-body irradiation.

Authors:  P J Selby; J M Thomas; P Monaghan; J Sloane; M J Peckham
Journal:  Br J Cancer       Date:  1980-01       Impact factor: 7.640

View more
  100 in total

1.  Follicle Depletion Provides a Permissive Environment for Ovarian Carcinogenesis.

Authors:  Ying Wang; Kathy Qi Cai; Elizabeth R Smith; Toni M Yeasky; Robert Moore; Parvin Ganjei-Azar; Andres J Klein-Szanto; Andrew K Godwin; Thomas C Hamilton; Xiang-Xi Xu
Journal:  Mol Cell Biol       Date:  2016-08-26       Impact factor: 4.272

2.  Xenopatients 2.0: reprogramming the epigenetic landscapes of patient-derived cancer genomes.

Authors:  Javier A Menendez; Tomás Alarcón; Bruna Corominas-Faja; Elisabet Cuyàs; Eugeni López-Bonet; Angel G Martin; Luciano Vellon
Journal:  Cell Cycle       Date:  2014-01-09       Impact factor: 4.534

Review 3.  The microbiome and gynaecological cancer development, prevention and therapy.

Authors:  Paweł Łaniewski; Zehra Esra Ilhan; Melissa M Herbst-Kralovetz
Journal:  Nat Rev Urol       Date:  2020-02-18       Impact factor: 14.432

4.  Anti-PD-L1 prolongs survival and triggers T cell but not humoral anti-tumor immune responses in a human MUC1-expressing preclinical ovarian cancer model.

Authors:  Jyothi Thyagabhavan Mony; Lixin Zhang; Tianzhou Ma; Shannon Grabosch; Tejas S Tirodkar; Joan Brozick; George Tseng; Esther Elishaev; Robert P Edwards; Xin Huang; Anda M Vlad
Journal:  Cancer Immunol Immunother       Date:  2015-05-22       Impact factor: 6.968

Review 5.  Preclinical Models of Ovarian Cancer: Pathogenesis, Problems, and Implications for Prevention.

Authors:  Anthony N Karnezis; Kathleen R Cho
Journal:  Clin Obstet Gynecol       Date:  2017-12       Impact factor: 2.190

Review 6.  Marine Mollusk-Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance.

Authors:  Maria Letizia Ciavatta; Florence Lefranc; Marianna Carbone; Ernesto Mollo; Margherita Gavagnin; Tania Betancourt; Ramesh Dasari; Alexander Kornienko; Robert Kiss
Journal:  Med Res Rev       Date:  2016-12-07       Impact factor: 12.944

7.  Genome-Wide Interrogation of Human Cancers Identifies EGLN1 Dependency in Clear Cell Ovarian Cancers.

Authors:  Colles Price; Stanley Gill; Zandra V Ho; Shawn M Davidson; Erin Merkel; James M McFarland; Lisa Leung; Andrew Tang; Maria Kost-Alimova; Aviad Tsherniak; Oliver Jonas; Francisca Vazquez; William C Hahn
Journal:  Cancer Res       Date:  2019-03-21       Impact factor: 12.701

8.  Quantitative Proteomic and Phosphoproteomic Comparison of 2D and 3D Colon Cancer Cell Culture Models.

Authors:  Xiaoshan Yue; Jessica K Lukowski; Eric M Weaver; Susan B Skube; Amanda B Hummon
Journal:  J Proteome Res       Date:  2016-10-10       Impact factor: 4.466

9.  MiR-200c-3p Contrasts PD-L1 Induction by Combinatorial Therapies and Slows Proliferation of Epithelial Ovarian Cancer through Downregulation of β-Catenin and c-Myc.

Authors:  Eleni Anastasiadou; Elena Messina; Tiziana Sanavia; Lucia Mundo; Federica Farinella; Stefano Lazzi; Francesca Megiorni; Simona Ceccarelli; Paola Pontecorvi; Francesco Marampon; Cira Rosaria Tiziana Di Gioia; Giorgia Perniola; Pierluigi Benedetti Panici; Lorenzo Leoncini; Pankaj Trivedi; Andrea Lenzi; Cinzia Marchese
Journal:  Cells       Date:  2021-03-01       Impact factor: 6.600

10.  Obesity Contributes to Ovarian Cancer Metastatic Success through Increased Lipogenesis, Enhanced Vascularity, and Decreased Infiltration of M1 Macrophages.

Authors:  Yueying Liu; Matthew N Metzinger; Kyle A Lewellen; Stephanie N Cripps; Kyle D Carey; Elizabeth I Harper; Zonggao Shi; Laura Tarwater; Annie Grisoli; Eric Lee; Ania Slusarz; Jing Yang; Elizabeth A Loughran; Kaitlyn Conley; Jeff J Johnson; Yuliya Klymenko; Lana Bruney; Zhong Liang; Norman J Dovichi; Bentley Cheatham; W Matthew Leevy; M Sharon Stack
Journal:  Cancer Res       Date:  2015-11-16       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.